Why North America’s Largest Food Companies Are Betting Big on the Plant-Based Innovation
FN Media Group Presents Microsmallcap.com Market Commentary
New York, NY – December 19, 2019 – The plant-based food market is growing exponentially and completely disrupting the global meat and dairy sector, causing major meat producers Maple Leaf Foods Inc. (TSX:MFI) (OTCPK:MLFNF), Tyson Foods Inc. (NYSE:TSN) and packaged foods company ConAgra Brands, Inc. (NYSE:CAG) to shift their focus and create plant-based meat alternatives to satisfy consumer needs. Even fast-food giant McDonald’s Corp (NYSE:MCD) has changed gears after seeing an 80% increase in vegetarian orders over the last year. Meanwhile, the global plant-based milk market is worth an estimated $14 billion USD and growing at a CAGR of 8%, offering 100% plant-based companies like Else Nutrition (TSX-V:BABY) (OTCQB:BABYF) a lucrative opportunity.
While other companies focus on infiltrating the saturated alt-meat market, Else Nutrition (TSXV:BABY) (OTCQB:BABYF) is looking to disrupt the $90 billion global infant formula market by 2025 with its 100% plant-based non-dairy non-soy products for babies and children
Plant-based products, which were previously reserved for the niche consumer and warranted limited shelf space, have now gone mainstream. In fact, 80% of Americans plan to replace at least some meat for plant-based alternatives. Naturally, food companies are moving quickly to gain a piece of the global plant-based food and beverage alternatives market, which is on track to hit $80 billion by 2024 due to an uptick in health-conscious consumers, rising concerns for animal welfare and increasing demand for food safety.
Plant-Based Milk Market Still Holds the Top Spot
Despite the endless buzz surrounding the alt-meat market, the plant-based milk sector takes the cake in terms of sales revenue. Last year, plant-based milk sales grew by 9% from the previous year, netting $1.8 billion in sales.
According to experts, consumers are making the switch to plant-based milk for health reasons, intolerance to dairy, ethical concerns about animal abuse in dairy farming, or for simply wanting another alternative to dairy, even if it comes at a premium.
At the same time, parents are shying away from dairy products for their babies because of the antibiotics, hormones, and pesticide traces found in cow’s milk, as well as the impact the dairy industry has on the environment and animal welfare. Fortunately, Else Nutrition (BABY.V – BABYF.QB) is swooping in to provide a much-needed 100% plant-based dairy-free and soy-free alternative.
Else Nutrition (BABY.V – BABYF.QB) patented baby formula is made from a combination of three plants which constitute 95% of the formula, has a clean label compared to its competitors, is free of antibiotics, gluten, hormones, and GMOs, has a minor ecological footprint, and has no external addition of purified oils.
The company’s proprietary formulation has been granted composition patents in 19 countries including the US, Australia, South Africa, Japan, Israel, Eurasia, and New Zealand and has an additional 47 patents pending.
Else Nutrition (BABY.V – BABYF.QB) also just received a favorable regulatory assessment of its toddler formula ingredients from EAS Consulting Group, which conducted a preliminary review of the Else formula in view of U.S. Food and Drug Administration (F.D.A.) requirements.
Major Meat Companies Jumping on the Plant-Based Bandwagon
While companies like Else Nutrition (BABY.V – BABYF.QB) are strictly 100% plant-based, food giants like Maple Leaf Foods and Tyson Foods are moving into new territory in a bid to launch plant-based products to the ever-growing alt-meat market. Strategic investments and M&A activity have heated up in the sector, with $17 billion being invested in U.S. plant-based meat, egg, and dairy companies since 2009, including $13 billion in 2017 and 2018 alone and major corporations like ConAgra Brands, Inc. (NYSE:CAG) are acquiring plant-based companies to round out their alt-meat product offerings.
Canadian consumer packaged meats company Maple Leaf Foods Inc. (TSX:MFI) (OTCMKTS:MLFNF) entered the plant-based market race in 2017 after acquiring Lightlife Foods Holding Inc. and Field Roast Grain Meat Company to serve as a foundation for its meatless protein business. Since being acquired by Maple Leaf, Lightlife has amped up its product portfolio and is now available in over 12,000 retailers across the US, as well as in restaurants like Dave & Busters. Meanwhile, Field Roast Grain Meat partnered with Pizza Pizza to launch the chain’s first-ever plant-based pizza. Then in April, Maple Leaf announced its plan to build a $310 million USD plant-based food processing facility in Indiana to double its current production capacity.
Major U.S. meat producer Tyson Foods Inc. (NYSE:TSN), which was an early investor in Beyond Meat, honed in on the plant-based market with the launch of its Raised & Rooted brand in June, offering plant-based nuggets and a blended burger in over 7,000 stores. Then in September, Tyson Foods invested in New Wave Foods to produce plant-based shellfish for food service operators in early 2020.
No End in Sight for Plant-Based Food Adoption
As the global meat sector continues to face unprecedented competition and disruption, investors will likely see more companies like Maple Leaf Foods Inc, Tyson Foods Inc. and ConAgra Brands, Inc. entering the plant-based food market. At the same time, major fast-food chains like McDonald’s Corp (NYSE:MCD) will likely continue to add plant-based options to their menus in a bid to capture this growing market.
The dairy sector will also face major changes in the coming months and years, as dairy farms continue to shut their doors due to lackluster sales numbers and as consumers shift to plant-based milks for health reasons. Major companies like Nestle have begun creating products for the $14 billion USD plant-based milk market, but Else Nutrition (BABY.V – BABYF.QB) is already ahead of the game with its toddler formula expected to launch in early 2020 in the U.S. in powder form. The company’s infant formula is estimated to reach the market in the next two or three years.
Disclaimer: Microsmallcap.com (MSC) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Else Nutrition
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC and FNM undertake no obligation to update such statements.
FN Media Group, LLC